FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1965284073> ?p ?o ?g. }

• W1965284073 endingPage "1491" @default.
• W1965284073 startingPage "1478" @default.
• W1965284073 abstract "The tetranuclear complexes [Fe(4)(pypentO)(pym)(3)(Oac)(NCS)(3)] x 1.5EtOH (1), [Fe(4)(pypentO)(pym)(Oac)(2)(NCS)(2)(MeO)(2)(H(2)O)] x H(2)O (2), [Fe(2)(pypentO)(NCO)(3)](2) (3), and [Fe(2)(pypentO)(N(3))(3)](2) (4) have been prepared, and their structure and magnetic properties have been studied (pypentOH = 1,5-bis[(2-pyridylmethyl)amino]pentan-3-ol, pymH = 2-pyridylmethanol). The X-ray diffraction analysis of 1 (C(43)H(53)N(10)O(7.5)S(3)Fe(4), monoclinic, P2(1)/n, a = 11.6153(17) A, b = 34.391(17) A, c = 14.2150(18) A, beta = 110.88(5) degrees, V = 5305(3) A(3), Z = 4) and 2 (C(31)H(45)N(7)O(10)S(2)Fe(4), monoclinic, C2/c, a = 19.9165(17) A, b = 21.1001(12) A, c = 21.2617(19) A, beta = 104.441(10) degrees, V = 8652.7(12) A(3), Z = 8) showed a Fe(4)O(4) cubane-like arrangement of four iron(II) atoms, four mu(3)-O bridging ligands, one (1) or two (2) syn-syn bridging acetates. The X-ray diffraction analysis of 3 (C(40)H(46)N(14)O(8)Fe(4), monoclinic, P2(1)/c, a = 11.7633(18) A, b = 18.234(3) A, c = 10.4792(16) A, beta = 99.359(18) degrees, V = 2217.7(6) A(3), Z = 2) and 4 (C(34)H(46)N(26)O(2)Fe(4), monoclinic, P2(1)/c, V = 4412.4(10) A(3), a = 23.534(3) A, b = 18.046(2) A, c = 10.4865(16) A, beta = 97.80(2) degrees, Z = 4) showed a zigzag bis-dinuclear arrangement of four iron(II) cations, two mu(2)-O bridging pypentO ligands, four mu(2)-N-cyanato bridging ligands (3) or four end-on azido bridging ligands (4): they are the first examples of cyanato and azido bridged discrete polynuclear ferrous compounds, respectively. The Mössbauer spectra of 1 are consistent with four different high-spin iron(II) sites in the Fe(4)O(4) cubane-type structure. The Mössbauer spectra of 3 are consistent with two high-spin iron(II) sites (N(5)O and N(4)O). Below 190 K, the Mössbauer spectra of 4 are consistent with one N(5)O and two N(4)O high-spin iron(II) sites. The temperature dependence of the magnetic susceptibility was fitted with J(1) approximately 0 cm(-1), J(2) = -1.3 cm(-1), J(3) = 4.6 cm(-1), D = 6.4 cm(-1), and g = 2.21 for 1; J(1) = 2.6 cm(-1), J(2) = 2.5 cm(-1), J(3) = - 5.6 cm(-1), D = 4.5 cm(-1), and g = 2.09 for 2; J(1) = 1.5 cm(-1), J(2) = 0.2 cm(-1), D = - 5.6 cm(-1), D' = 4.5 cm(-1), and g = 2.14 for 3; and J(1) = - 2.6 cm(-1), J(2) = 0.8 cm(-1), D= 6.3 cm(-1), D' = 1.6 cm(-1), and g = 2.18 for 4. The differences in sign among the J(1), J(2), and J(3) super-exchange interactions indicate that the faces including only mu(3)-OR bridges exhibit ferromagnetic interactions. The nature of the ground state in 1-3 is confirmed by simulation of the magnetization curves at 2 and 5 K. In the bis-dinuclear iron(II) compounds 3 and 4, the J(2) interaction resulting from the bridging of two Fe(2)(pypentO)X(3) units through two pseudo-halide anions is ferromagnetic in 3 (X = mu(2)-N-cyanato) and may be either ferro- or antiferromagnetic in 4 (X = end-on azido). The J(1) interaction through the central O(alkoxo) and pseudo-halide bridges inside the dinuclear units is ferromagnetic in 3 (X = mu(2)-N-cyanato) and antiferromagnetic in 4 (X = end-on azido). In agreement with the symmetry of the two Fe(II) sites in complexes 3 and 4, D (pentacoordinated sites) is larger than D' (octahedral sites)." @default.
• W1965284073 created "2016-06-24" @default.
• W1965284073 creator A5003558008 @default.
• W1965284073 creator A5005648652 @default.
• W1965284073 creator A5012439213 @default.
• W1965284073 creator A5020055544 @default.
• W1965284073 creator A5033380540 @default.
• W1965284073 creator A5082964773 @default.
• W1965284073 creator A5089288840 @default.
• W1965284073 date "2002-02-20" @default.
• W1965284073 modified "2023-10-18" @default.
• W1965284073 title "Synthesis, Structure, and Magnetic Properties of Tetranuclear Cubane-like and Chain-like Iron(II) Complexes Based on the N₄O Pentadentate Dinucleating Ligand 1,5-Bis[(2-pyridylmethyl)amino]pentan-3-ol" @default.
• W1965284073 cites W1412314984 @default.
• W1965284073 cites W1973874710 @default.
• W1965284073 cites W1980207721 @default.
• W1965284073 cites W1983977677 @default.
• W1965284073 cites W1990450903 @default.
• W1965284073 cites W1991102844 @default.
• W1965284073 cites W1992486067 @default.
• W1965284073 cites W1992722221 @default.
• W1965284073 cites W1993294589 @default.
• W1965284073 cites W1994031154 @default.
• W1965284073 cites W2000619473 @default.
• W1965284073 cites W2003115721 @default.
• W1965284073 cites W2006111944 @default.
• W1965284073 cites W2010083907 @default.
• W1965284073 cites W2013903780 @default.
• W1965284073 cites W2014560678 @default.
• W1965284073 cites W2017285046 @default.
• W1965284073 cites W2020630776 @default.
• W1965284073 cites W2022910041 @default.
• W1965284073 cites W2025108578 @default.
• W1965284073 cites W2026158184 @default.
• W1965284073 cites W2029741135 @default.
• W1965284073 cites W2032181806 @default.
• W1965284073 cites W2032223463 @default.
• W1965284073 cites W2035277916 @default.
• W1965284073 cites W2038077864 @default.
• W1965284073 cites W2038305760 @default.
• W1965284073 cites W2043680012 @default.
• W1965284073 cites W2055008799 @default.
• W1965284073 cites W2060203113 @default.
• W1965284073 cites W2060634119 @default.
• W1965284073 cites W2061032371 @default.
• W1965284073 cites W2063695143 @default.
• W1965284073 cites W2070634545 @default.
• W1965284073 cites W2071884003 @default.
• W1965284073 cites W2079580223 @default.
• W1965284073 cites W2082840570 @default.
• W1965284073 cites W2085823060 @default.
• W1965284073 cites W2090031552 @default.
• W1965284073 cites W2092396024 @default.
• W1965284073 cites W209433882 @default.
• W1965284073 cites W2094377342 @default.
• W1965284073 cites W2104416303 @default.
• W1965284073 cites W2131025786 @default.
• W1965284073 cites W2140906947 @default.
• W1965284073 cites W2143452734 @default.
• W1965284073 cites W2158141385 @default.
• W1965284073 cites W2315634395 @default.
• W1965284073 cites W4231960227 @default.
• W1965284073 cites W1976778417 @default.
• W1965284073 doi "https://doi.org/10.1021/ic010787+" @default.
• W1965284073 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11896717" @default.
• W1965284073 hasPublicationYear "2002" @default.
• W1965284073 type Work @default.
• W1965284073 sameAs 1965284073 @default.
• W1965284073 citedByCount "78" @default.
• W1965284073 countsByYear W19652840732012 @default.
• W1965284073 countsByYear W19652840732014 @default.
• W1965284073 countsByYear W19652840732015 @default.
• W1965284073 countsByYear W19652840732016 @default.
• W1965284073 countsByYear W19652840732017 @default.
• W1965284073 countsByYear W19652840732018 @default.
• W1965284073 countsByYear W19652840732019 @default.
• W1965284073 countsByYear W19652840732021 @default.
• W1965284073 countsByYear W19652840732022 @default.
• W1965284073 crossrefType "journal-article" @default.
• W1965284073 hasAuthorship W1965284073A5003558008 @default.
• W1965284073 hasAuthorship W1965284073A5005648652 @default.
• W1965284073 hasAuthorship W1965284073A5012439213 @default.
• W1965284073 hasAuthorship W1965284073A5020055544 @default.
• W1965284073 hasAuthorship W1965284073A5033380540 @default.
• W1965284073 hasAuthorship W1965284073A5082964773 @default.
• W1965284073 hasAuthorship W1965284073A5089288840 @default.
• W1965284073 hasConcept C115624301 @default.
• W1965284073 hasConcept C116569031 @default.
• W1965284073 hasConcept C120665830 @default.
• W1965284073 hasConcept C121332964 @default.
• W1965284073 hasConcept C170493617 @default.
• W1965284073 hasConcept C185592680 @default.
• W1965284073 hasConcept C207114421 @default.
• W1965284073 hasConcept C2780750454 @default.
• W1965284073 hasConcept C50515024 @default.
• W1965284073 hasConcept C55352516 @default.
• W1965284073 hasConcept C55493867 @default.
• W1965284073 hasConcept C61276311 @default.
• W1965284073 hasConcept C71240020 @default.

• next